Expanding Access And Aging Demographics Will Redefine Diagnostics
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
04 Aug 25
Updated
16 Aug 25
AnalystHighTarget's Fair Value
US$60.00
56.8% undervalued intrinsic discount16 Aug
US$25.93
1Y
-41.0%7D
8.4%